Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB plus ) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C
No Thumbnail Available
Identifiers
Date
2021-09-21
Authors
Dziadziuszko, R.
Peters, S.
Gadgeel, S. M.
Mathisen, M. S.
Shagan, S. M.
Felip, E.
Morabito, A.
Cheema, P.
Cobo Dols, M.
Andric, Z.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
